English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Financial Venture Capital & PE
Perseverance Asset Management: long bias and fundamental bottom-up strategy
Jun 28, 2022 15:00 HKT
Panthera Growth to Raise US$250 Million Second Fund to Back Tech Companies
Jun 28, 2022 12:00 HKT
Legend Capital Increases Carbon Neutrality Investments: Portfolio Company Talent New Energy Completes A++ Financing Round with Several Hundred Million RMB
Jun 16, 2022 11:00 HKT
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Jun 15, 2022 12:08 HKT
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange
Jun 09, 2022 17:49 HKT
Hong Kong Investment Promotion Chief visits Middle East and Europe to promote Hong Kong's long-term business opportunities
May 30, 2022 06:00 HKT
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products
May 27, 2022 10:00 HKT
Soluna Raises $35M from Spring Lane Capital to Build Green Data Centers for Crypto, Machine Learning
May 12, 2022 20:00 HKT
Society Pass Inc (Nasdaq: SOPA) Reports 1Q 2022 Financial Results, Sees 4,582% Year on Year Revenue Growth and Cash on Hand Growth of 33% from year 2021
May 12, 2022 11:00 HKT
Society Pass(SoPa)(社會通行有限公司)报告 2022 年第一季度财务业绩,收入同比增长 4,582%,存留现金自 2021 年起增长 33%
May 12, 2022 11:00 HKT
Society Pass(SoPa)(社會通行有限公司)報告 2022 年第一季度財務業績,收入同比增長 4,582%,存留現金自 2021 年起增長 33%
May 12, 2022 11:00 HKT
CleverTap Appoints Honey Bajaj as SVP & Global Chief of Consumer Experience
May 05, 2022 15:00 HKT
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Apr 27, 2022 16:09 HKT
Venturi Partners mencapai penutupan akhir dana perdana sebesar USD 175 juta
Apr 27, 2022 10:00 HKT
Venturi Partners ปิดตลาดครั้งสุดท้ายที่ 175 ล้านเหรียญสหรัฐ ในกองทุนเปิดใหม่
Apr 27, 2022 10:00 HKT
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022
Apr 26, 2022 18:07 HKT
Venturi Partners Hits Final Close of USD 175M in Maiden Fund
Apr 26, 2022 11:30 HKT
君联资本联合创建企业朗信生物遗传性视网膜变性基因治疗产品在中国获批临床
Apr 24, 2022 17:02 HKT
君聯資本聯合創建企業朗信生物遺傳性視網膜變性基因治療產品在中國獲批臨床
Apr 24, 2022 17:01 HKT
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Apr 24, 2022 17:00 HKT
Next >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: